- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Healthcare
Serum Likely To Supply COVID-19 Vaccine At Over $3 A Dose To Indian Government
The government is pinning its hopes for mass supply on Serum Institute, which lodged the first formal application for emergency-use approval of AstraZeneca's shot on Monday.
Read More
Delhi Govt Tells Healthcare Facilities To Submit HCWs Data For COVID Vaccination
Hundreds of healthcare workers (HCWs) at government and private facilities in Delhi had contracted the novel coronavirus, and many more are still getting affected by it.
Read More
Serum Institute Rejects Charges Levelled By Vaccine Trial Participant, threatens to seek damages
The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent
Read More
AstraZeneca Manufacturing Error Clouds Vaccine Study Results
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
Read More
When And How Will COVID-19 Vaccines Become Available?
If regulators approve any of the vaccines in coming weeks, the companies have said distribution could begin almost immediately with governments around the world to decide who gets them and in what order. The following is an outline of the process:
Read More
Oxford University Vaccine ‘Effective’ At Preventing COVID-19; Shows 70% Protection
The ChAdOx1 nCoV-2019, being produced in collaboration with AstraZeneca, was found to be 70.4 per cent effective when combining data from two dosing regimens.
Read More
AstraZeneca: COVID-19 Vaccine ''Highly Effective'' Prevention
A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday.
Read More
Strides Pharma Science gets USFDA nod for Prednisone tablets
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Deltasone tablets, 2.5 mg and 5 mg, of Pharmacia and Upjohn Co
Read More
Govt To Provide Industrial Park Facilities To Grow API, Pharma & Nutraceutical Industry
Indian pharma industry will continue to play a prominent role as the pharmacy of the world, the Chemicals and Fertilizers Ministry said in a statement.
Read More
India's Gland Pharma jumps 20% in market debut
The stock opened at 1,710 rupees per share, higher than the IPO price of 1,500 rupees per share, giving the company a market value of 279.21 billion rupees, based on 163.3 million shares outstanding.
Read More
Pfizer, BioNTech Conclude Phase 3 Study Of COVID-19 Vaccine Candidate, Say It's 95% Effective
The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent
Read More
Pfizer Moves US Court Against Aurobindo Pharma, Dr Reddy's On Cancer Drug
The generic companies assert the invalidity and non- infringement of two composition of matter patents and a method of use patent covering palbociclib, each of which expire in 2023
Read More
What does COVID-19 vaccine effectiveness mean?
Two vaccine makers have said that preliminary results from their late-stage studies suggest their experimental vaccines are strongly protective. Moderna this week said its vaccine appears nearly 95 per cent effective.
Read More
Asian Shares Rise Buoyed By News On Coronavirus Vaccine
It's the second time this month that a company unveiled such encouraging numbers about a vaccine, boosting hopes that the global economy can return to some semblance of normal next year.
Read More
Vaccine alliance raises $2 billion to buy COVID shots for poor nations
Another $5 billion will also be needed in 2021 to procure COVID-19 vaccine doses as they come through development and are approved by regulators
Read More